Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175551 · ClinicalTrials.gov registry record
Direct Measurements of Cervical Remodeling for Predicting Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,207
- Enrollment target
NCT01175551: Completed study, sponsored by University of Pennsylvania.
NCT01175551 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 1,207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01175551 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,207 participants
- Enrollment target
Study Summary
Racism and health care system distrust are potent stressors and may be associated with preterm birth (PTB). Additionally, cervical shortening is a common pathway leading to PTB. This study is enrolling a prospective cohort of pregnant women. The study assesses racial discrimination, health care system distrust, and cervical change using 2 questionnaires, exam, and protein levels in cervical vaginal fluid and maternal serum.
Primary Outcome
16-37 weeks from enrollment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,207 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-05 |
What the finished NCT01175551 record still lists
NCT01175551 is an observational study that tracks outcomes without assigning an intervention. Its 1,207 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01175551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01175551 about?
NCT01175551 is a clinical study titled "Direct Measurements of Cervical Remodeling for Predicting Preterm Birth". Racism and health care system distrust are potent stressors and may be associated with preterm birth (PTB). Additionally, cervical shortening is a common pathway leading to PTB. This study is enrolling a prospective cohort of pregnant women. The study assesses racial discrimination, health care syst...
What is the current status of trial NCT01175551?
This trial is currently completed. The enrollment target is 1,207 participants. The study started on 2009-11. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01175551?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia